Target intelligence / Profile preview

Hemoglobin subunit gamma-1 (HBG1) (HBG1)

Target
HBG1
Molecular classification
Oxygen transport protein, Other
01

Overview

Hemoglobin subunit gamma-1 (HBG1) and its paralog gamma-2 (HBG2) are the protein components of fetal hemoglobin (HbF), the primary oxygen carrier during fetal development. HbF possesses a higher affinity for oxygen than adult hemoglobin (HbA), facilitating the extraction of oxygen from maternal circulation across the placenta. Shortly after birth, a developmental switch occurs where HbF production is silenced and replaced by adult hemoglobin, a process regulated by repressors such as BCL11A. In patients with hemoglobinopathies like sickle cell disease or beta-thalassemia, reactivating the expression of these fetal hemoglobin genes can compensate for the lack of functional adult beta-globin. Modern therapeutic strategies, including CRISPR-based gene editing of the BCL11A enhancer or direct gene addition of modified gamma-globin sequences, aim to induce high levels of HbF to prevent the polymerization of sickle hemoglobin and improve erythropoiesis.

Other names
HBG1HBG2Gamma-globinHbFFetal hemoglobinHemoglobin subunit gamma-2
02

Mechanism of action

Induction of fetal hemoglobin expression via BCL11A inhibition or direct gene addition

03

Biological functions

Oxygen transportHeme bindingFetal oxygenation
04

Disease associations

Sickle cell diseaseBeta-thalassemia
05

Safety considerations

Off-target genomic alterationsInsertional mutagenesisClonal hematopoiesisToxicity from myeloablative conditioning
06

Interacting drugs

Exagamglogene autotemcel

4 more in the full profile.

07

Biomarkers

Fetal hemoglobin (HbF) percentageF-cell countTotal hemoglobin levels

Beyond the preview

Go deeper on Hemoglobin subunit gamma-1 (HBG1) (HBG1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemoglobin subunit gamma-1 (HBG1) (HBG1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call